Medivation Announces Participation at Upcoming Investor

Medivation Announces Participation at Upcoming Investor Conferences 
SAN FRANCISCO, CA -- (Marketwire) -- 11/29/12 --  Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
conferences: 


 
--  David Hung, M.D., president and chief executive officer, will present
    at the Deutsche Bank BioFEST Conference on December 3 at 9:35am
    Eastern Time in Boston, MA.
--  David Hung, M.D., president and chief executive officer, will present
    at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific
    Time in San Francisco, CA.

  
About Medivation
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com. 
Contacts:
Patrick Machado
Chief Business & Financial Officer 
(415) 829-4101  
Anne Bowdidge
Sr. Director
Investor Relations
(650) 218-6900 
 
 
Press spacebar to pause and continue. Press esc to stop.